img

Global Bisphosphonate Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bisphosphonate Drug Market Insights, Forecast to 2034

Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
Global Bisphosphonate Drug market is expected to reach to US$ 870 million in 2024, with a positive growth of %, compared with US$ 854 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Bisphosphonate Drug industry is evaluated to reach US$ 1241.1 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Bisphosphonate Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bisphosphonate Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Type
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug

Segment by Application


Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Bisphosphonate Drug plant distribution, commercial date of Bisphosphonate Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Bisphosphonate Drug introduction, etc. Bisphosphonate Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Bisphosphonate Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Bisphosphonate Drug Product Introduction
1.2 Market by Type
1.2.1 Global Bisphosphonate Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Alendronate
1.2.3 Risedronate
1.2.4 Zoledronic Acid
1.2.5 Other Bisphosphonate Drug
1.3 Market by Application
1.3.1 Global Bisphosphonate Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.3.4 Paget’s Disease
1.3.5 Bone Loss Caused by Cancer Treatment
1.3.6 Osteoporosis Imperfecta in Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bisphosphonate Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Bisphosphonate Drug Revenue by Region
2.2.1 Global Bisphosphonate Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bisphosphonate Drug Revenue by Region (2018-2024)
2.2.3 Global Bisphosphonate Drug Revenue by Region (2024-2029)
2.2.4 Global Bisphosphonate Drug Revenue Market Share by Region (2018-2029)
2.3 Global Bisphosphonate Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Bisphosphonate Drug Sales by Region
2.4.1 Global Bisphosphonate Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bisphosphonate Drug Sales by Region (2018-2024)
2.4.3 Global Bisphosphonate Drug Sales by Region (2024-2029)
2.4.4 Global Bisphosphonate Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bisphosphonate Drug Sales by Manufacturers
3.1.1 Global Bisphosphonate Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Bisphosphonate Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bisphosphonate Drug in 2022
3.2 Global Bisphosphonate Drug Revenue by Manufacturers
3.2.1 Global Bisphosphonate Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Bisphosphonate Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Bisphosphonate Drug Revenue in 2022
3.3 Global Key Players of Bisphosphonate Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Bisphosphonate Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bisphosphonate Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bisphosphonate Drug, Product Offered and Application
3.8 Global Key Manufacturers of Bisphosphonate Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bisphosphonate Drug Sales by Type
4.1.1 Global Bisphosphonate Drug Historical Sales by Type (2018-2024)
4.1.2 Global Bisphosphonate Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Bisphosphonate Drug Sales Market Share by Type (2018-2029)
4.2 Global Bisphosphonate Drug Revenue by Type
4.2.1 Global Bisphosphonate Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Bisphosphonate Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
4.3 Global Bisphosphonate Drug Price by Type
4.3.1 Global Bisphosphonate Drug Price by Type (2018-2024)
4.3.2 Global Bisphosphonate Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bisphosphonate Drug Sales by Application
5.1.1 Global Bisphosphonate Drug Historical Sales by Application (2018-2024)
5.1.2 Global Bisphosphonate Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Bisphosphonate Drug Sales Market Share by Application (2018-2029)
5.2 Global Bisphosphonate Drug Revenue by Application
5.2.1 Global Bisphosphonate Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Bisphosphonate Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
5.3 Global Bisphosphonate Drug Price by Application
5.3.1 Global Bisphosphonate Drug Price by Application (2018-2024)
5.3.2 Global Bisphosphonate Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bisphosphonate Drug Market Size by Type
6.1.1 US & Canada Bisphosphonate Drug Sales by Type (2018-2029)
6.1.2 US & Canada Bisphosphonate Drug Revenue by Type (2018-2029)
6.2 US & Canada Bisphosphonate Drug Market Size by Application
6.2.1 US & Canada Bisphosphonate Drug Sales by Application (2018-2029)
6.2.2 US & Canada Bisphosphonate Drug Revenue by Application (2018-2029)
6.3 US & Canada Bisphosphonate Drug Market Size by Country
6.3.1 US & Canada Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bisphosphonate Drug Sales by Country (2018-2029)
6.3.3 US & Canada Bisphosphonate Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bisphosphonate Drug Market Size by Type
7.1.1 Europe Bisphosphonate Drug Sales by Type (2018-2029)
7.1.2 Europe Bisphosphonate Drug Revenue by Type (2018-2029)
7.2 Europe Bisphosphonate Drug Market Size by Application
7.2.1 Europe Bisphosphonate Drug Sales by Application (2018-2029)
7.2.2 Europe Bisphosphonate Drug Revenue by Application (2018-2029)
7.3 Europe Bisphosphonate Drug Market Size by Country
7.3.1 Europe Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bisphosphonate Drug Sales by Country (2018-2029)
7.3.3 Europe Bisphosphonate Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bisphosphonate Drug Market Size
8.1.1 China Bisphosphonate Drug Sales (2018-2029)
8.1.2 China Bisphosphonate Drug Revenue (2018-2029)
8.2 China Bisphosphonate Drug Market Size by Application
8.2.1 China Bisphosphonate Drug Sales by Application (2018-2029)
8.2.2 China Bisphosphonate Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bisphosphonate Drug Market Size by Type
9.1.1 Asia Bisphosphonate Drug Sales by Type (2018-2029)
9.1.2 Asia Bisphosphonate Drug Revenue by Type (2018-2029)
9.2 Asia Bisphosphonate Drug Market Size by Application
9.2.1 Asia Bisphosphonate Drug Sales by Application (2018-2029)
9.2.2 Asia Bisphosphonate Drug Revenue by Application (2018-2029)
9.3 Asia Bisphosphonate Drug Sales by Region
9.3.1 Asia Bisphosphonate Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bisphosphonate Drug Revenue by Region (2018-2029)
9.3.3 Asia Bisphosphonate Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bisphosphonate Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bisphosphonate Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Mylan Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Apotex Corp
11.4.1 Apotex Corp Company Information
11.4.2 Apotex Corp Overview
11.4.3 Apotex Corp Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Apotex Corp Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Corp Recent Developments
11.5 Cobalt Pharmaceuticals
11.5.1 Cobalt Pharmaceuticals Company Information
11.5.2 Cobalt Pharmaceuticals Overview
11.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cobalt Pharmaceuticals Recent Developments
11.6 Genentech
11.6.1 Genentech Company Information
11.6.2 Genentech Overview
11.6.3 Genentech Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Genentech Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Genentech Recent Developments
11.7 Novartis Pharmaceuticals
11.7.1 Novartis Pharmaceuticals Company Information
11.7.2 Novartis Pharmaceuticals Overview
11.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Pharmaceuticals Recent Developments
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Information
11.8.2 Sanofi-Aventis Overview
11.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sanofi-Aventis Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi-Aventis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bisphosphonate Drug Industry Chain Analysis
12.2 Bisphosphonate Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bisphosphonate Drug Production Mode & Process
12.4 Bisphosphonate Drug Sales and Marketing
12.4.1 Bisphosphonate Drug Sales Channels
12.4.2 Bisphosphonate Drug Distributors
12.5 Bisphosphonate Drug Customers
13 Market Dynamics
13.1 Bisphosphonate Drug Industry Trends
13.2 Bisphosphonate Drug Market Drivers
13.3 Bisphosphonate Drug Market Challenges
13.4 Bisphosphonate Drug Market Restraints
14 Key Findings in The Global Bisphosphonate Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Bisphosphonate Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Alendronate
Table 3. Major Manufacturers of Risedronate
Table 4. Major Manufacturers of Zoledronic Acid
Table 5. Major Manufacturers of Other Bisphosphonate Drug
Table 6. Global Bisphosphonate Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Bisphosphonate Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Bisphosphonate Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Bisphosphonate Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Bisphosphonate Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Bisphosphonate Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Bisphosphonate Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Bisphosphonate Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Bisphosphonate Drug Sales by Region (2024-2029) & (K Units)
Table 15. Global Bisphosphonate Drug Sales Market Share by Region (2018-2024)
Table 16. Global Bisphosphonate Drug Sales Market Share by Region (2024-2029)
Table 17. Global Bisphosphonate Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Bisphosphonate Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Bisphosphonate Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Bisphosphonate Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Bisphosphonate Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Bisphosphonate Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Bisphosphonate Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Bisphosphonate Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bisphosphonate Drug as of 2022)
Table 25. Global Key Manufacturers of Bisphosphonate Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Bisphosphonate Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Bisphosphonate Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 30. Global Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 31. Global Bisphosphonate Drug Sales Share by Type (2018-2024)
Table 32. Global Bisphosphonate Drug Sales Share by Type (2024-2029)
Table 33. Global Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Bisphosphonate Drug Revenue Share by Type (2018-2024)
Table 36. Global Bisphosphonate Drug Revenue Share by Type (2024-2029)
Table 37. Bisphosphonate Drug Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Bisphosphonate Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 40. Global Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 41. Global Bisphosphonate Drug Sales Share by Application (2018-2024)
Table 42. Global Bisphosphonate Drug Sales Share by Application (2024-2029)
Table 43. Global Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Bisphosphonate Drug Revenue Share by Application (2018-2024)
Table 46. Global Bisphosphonate Drug Revenue Share by Application (2024-2029)
Table 47. Bisphosphonate Drug Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Bisphosphonate Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Bisphosphonate Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Bisphosphonate Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Bisphosphonate Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 62. Europe Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 63. Europe Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 64. Europe Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 67. Europe Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 68. Europe Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Bisphosphonate Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Bisphosphonate Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Bisphosphonate Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 74. Europe Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 75. China Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 76. China Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 77. China Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 80. China Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 81. China Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 84. Asia Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 85. Asia Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 88. Asia Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 89. Asia Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Bisphosphonate Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Bisphosphonate Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Bisphosphonate Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Bisphosphonate Drug Sales by Region (2018-2024) & (K Units)
Table 95. Asia Bisphosphonate Drug Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Bisphosphonate Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 109. Merck Company Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Merck Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Merck Recent Developments
Table 114. Teva Company Information
Table 115. Teva Description and Major Businesses
Table 116. Teva Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Teva Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Teva Recent Developments
Table 119. Mylan Company Information
Table 120. Mylan Description and Major Businesses
Table 121. Mylan Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Mylan Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Mylan Recent Developments
Table 124. Apotex Corp Company Information
Table 125. Apotex Corp Description and Major Businesses
Table 126. Apotex Corp Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Apotex Corp Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Apotex Corp Recent Developments
Table 129. Cobalt Pharmaceuticals Company Information
Table 130. Cobalt Pharmaceuticals Description and Major Businesses
Table 131. Cobalt Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Cobalt Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Cobalt Pharmaceuticals Recent Developments
Table 134. Genentech Company Information
Table 135. Genentech Description and Major Businesses
Table 136. Genentech Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Genentech Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Genentech Recent Developments
Table 139. Novartis Pharmaceuticals Company Information
Table 140. Novartis Pharmaceuticals Description and Major Businesses
Table 141. Novartis Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Novartis Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Novartis Pharmaceuticals Recent Developments
Table 144. Sanofi-Aventis Company Information
Table 145. Sanofi-Aventis Description and Major Businesses
Table 146. Sanofi-Aventis Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Sanofi-Aventis Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Sanofi-Aventis Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Bisphosphonate Drug Distributors List
Table 152. Bisphosphonate Drug Customers List
Table 153. Bisphosphonate Drug Market Trends
Table 154. Bisphosphonate Drug Market Drivers
Table 155. Bisphosphonate Drug Market Challenges
Table 156. Bisphosphonate Drug Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Bisphosphonate Drug Product Picture
Figure 2. Global Bisphosphonate Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bisphosphonate Drug Market Share by Type in 2022 & 2029
Figure 4. Alendronate Product Picture
Figure 5. Risedronate Product Picture
Figure 6. Zoledronic Acid Product Picture
Figure 7. Other Bisphosphonate Drug Product Picture
Figure 8. Global Bisphosphonate Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Bisphosphonate Drug Market Share by Application in 2022 & 2029
Figure 10. Postmenopausal Osteoporosis
Figure 11. Men with Osteoporosis
Figure 12. Paget’s Disease
Figure 13. Bone Loss Caused by Cancer Treatment
Figure 14. Osteoporosis Imperfecta in Children
Figure 15. Bisphosphonate Drug Report Years Considered
Figure 16. Global Bisphosphonate Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Bisphosphonate Drug Revenue 2018-2029 (US$ Million)
Figure 18. Global Bisphosphonate Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Bisphosphonate Drug Revenue Market Share by Region (2018-2029)
Figure 20. Global Bisphosphonate Drug Sales 2018-2029 ((K Units)
Figure 21. Global Bisphosphonate Drug Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Bisphosphonate Drug Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Bisphosphonate Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Bisphosphonate Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Bisphosphonate Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Bisphosphonate Drug Sales YoY (2018-2029) & (K Units)
Figure 27. China Bisphosphonate Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Bisphosphonate Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Bisphosphonate Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Bisphosphonate Drug Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Bisphosphonate Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Bisphosphonate Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Bisphosphonate Drug in the World: Market Share by Bisphosphonate Drug Revenue in 2022
Figure 34. Global Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 36. Global Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 37. Global Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 38. Global Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Bisphosphonate Drug Revenue Share by Country (2018-2029)
Figure 44. US & Canada Bisphosphonate Drug Sales Share by Country (2018-2029)
Figure 45. U.S. Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 48. Europe Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 49. Europe Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 50. Europe Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 51. Europe Bisphosphonate Drug Revenue Share by Country (2018-2029)
Figure 52. Europe Bisphosphonate Drug Sales Share by Country (2018-2029)
Figure 53. Germany Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 54. France Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 58. China Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 59. China Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 60. China Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 61. China Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 63. Asia Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 64. Asia Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 65. Asia Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 66. Asia Bisphosphonate Drug Revenue Share by Region (2018-2029)
Figure 67. Asia Bisphosphonate Drug Sales Share by Region (2018-2029)
Figure 68. Japan Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 72. India Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Bisphosphonate Drug Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Bisphosphonate Drug Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Bisphosphonate Drug Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Bisphosphonate Drug Sales Share by Country (2018-2029)
Figure 79. Brazil Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Bisphosphonate Drug Revenue (2018-2029) & (US$ Million)
Figure 84. Bisphosphonate Drug Value Chain
Figure 85. Bisphosphonate Drug Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries